Immunology Policy & Public Affairs Strategy Lead
UCB Pharma
Immunology Policy & Public Affairs Strategy Lead
UCB Pharma
Biopharmaceuticals for neurology and immunology therapies
Make your mark for patients
Immunology Policy & Public Affairs Strategy Lead
We are looking for a Pioneering, Curious, and Impact-driven Global Immunology Policy and Public Affairs Strategy Lead to join our Global Policy, Public Affairs and Payer Insights team, based at our UCB offices in Brussels, Belgium.
About the Role
At UCB, we are united by a simple purpose: creating value for people living with severe diseases. As our Immunology Policy & Public Affairs Strategy Lead, you will define and lead the overarching Policy & Public Affairs strategy and priorities for our global Immunology portfolio, while providing line management to senior colleagues. You will combine deep business understanding, strategic thinking and external insight to anticipate policy developments, identify opportunities and translate the evolving external environment into clear implications for our assets, patient access and commercial strategies. Through collaboration with disease-area ecosystems and internal partners, you will help position UCB to proactively shape policy environments that enable patient access to innovative healthcare solutions.
Who You'll Work With
You will join our Global Policy, Public Affairs & Payer Insights team, a diverse and collaborative team focused on improving patient outcomes by shaping policy and public affairs strategies and engaging with external stakeholders to influence disease-area and health-system environments. You will work closely with colleagues across Patient Access, Commercial, Medical, Regulatory, Communications and Patient Engagement, as well as regional and local teams.
What You'll Do
Interested? You bring:
Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!
About us
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.
Why work with us?
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.
At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.
UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [email protected]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.
Biopharmaceuticals for neurology and immunology therapies
UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.
Explore more opportunities at UCB Pharma